Alum Dr. Wallace Derricotte (Evangelista Group) has been awarded a Research Initiation Award from the National Science Foundation in the amount of $224,936. Wallace is currently an Assistant Professor of Chemistry at Morehouse College. The award, entitled “A Symmetry-Adapted Perturbation Theory Approach to Reaction Force Analysis”, will increase the research capacity of the Chemistry Department at Morehouse while creating more opportunities for STEM students.
Wallace received his B.S. in chemistry from Morehouse College in 2013 and his Ph.D. from Emory in 2017. During his time at Emory, he received the prestigious NSF Graduate Research Fellowship Award.
Emory University was recently named as a recipient of a grant from The Association of American Universities for the improvement of undergraduate education in science, technology, engineering, and mathematics (STEM) disciplines. The grant is part of the AAU Undergraduate STEM Education Initiative, a project launched in 2011 to encourage STEM departments to maximize student engagement through effective teaching strategies. The AAU explains:
“These strategies include creating learning communities for STEM faculty members involved in reform efforts, establishing programs to train graduate students and undergraduate teaching assistants or peer advisors in active learning practices, renovating classrooms into collaborative learning spaces, and creating inclusive and welcoming learning environments for all students.”
The mission of this initiative aligns perfectly with Chemistry Unbound, our undergraduate curriculum, that has seen great success since its start in Fall 2017.
“A ‘classical’ chemist is focused on getting a chemical reaction and creating new molecules,” explains Evangelista, assistant professor at Emory University. “As theoretical chemists, we want to understand how chemistry really works — how all the atoms involved interact with one another during a reaction.”
Victor Ma, a fourth-year graduate student in the lab of Dr. Khalid Salaita, was recently selected as one of twenty-six Predoctoroal to Postdoctoral Fellow Transition Award Fellows from the National Institute of Health. This award will provide Victor with two years of funding to complete his doctoral thesis and an additional four years of funding for future postdoc training. In the Salaita lab, with co-mentorship by Dr. Brian Evavold, Victor’s research focuses on developing technologies to study mechanobiology at the molecular scale. With an ultimate goal of establishing an alternative mechanism for regulating T cell activity, he studies the roles of mechanical forces in T cell activation, whether these forces are coordinately controlled by mechano-sensitive proteins, and the importance of these forces for T cell biological function. The findings from these studies can provide insight into a potential strategy for developing effective immunotherapies.
In his postdoc, Victor plans on transitioning into the field of tumor immunology, where he hopes to capitalize on his skillset to elucidate the physical mechanisms responsible for preventing T cells from interacting with tumor cells. “My ultimate career goal is to become an independent investigator at a research-intensive university, where I can assume teaching duties and direct a research lab that combines knowledge from various disciplines to innovate career research,” says Victor. “This award will surely serve as a stepping stone to help achieve my goal!”
ChEmory, Emory’s undergraduate chemistry club, has been recognized by the American Chemical Society as a Commendable chapter for 2016-2017. This places ChEmory in the top 10-20% of all undergraduate ACS chapters.
2017-2018 is also shaping up to be an excellent year for ChEmory. The club has been awarded two ACS grants for activities–a Community Interaction Grant and a New Activities Grant.
Congrats to the ChEmory officers and members for all their hard work!
Emory’s Center for Selective C-H Functionalization has received a five year, $20 million renewal from the National Science Foundation. The CCHF is part of NSF’s Centers for Chemical Innovation (CCI) program that supports research centers focused on major, long-term fundamental chemical research challenges. The CCHF aims to bring about a paradigm shift in the logic of chemical synthesis, one that has the potential to impact the construction of all organic molecules. The Center is headquartered at Emory, but has satellite centers at research universities across the U.S. and internationally including UC Berkeley, Stanford, Princeton, and Georgia Tech, among others. The CCHF also works with industrial collaborators, including Novartis, Merck, and AbbVie.
Center Director Huw Davies says, “We are very excited with this opportunity because we feel the momentum of the CCHF continues to build. An Outlook of the CCHF has just been published, which summarizes what we have achieved so far and where we plan to go in the future.”
As with all CCI, the CCHF also has an outreach mission, seeking to share their science with the public. They are regular participants in the Atlanta Science Festival and sponsors of the Graduate School Prep Club. The CCHF has also pioneered the use of virtual symposia offering talks by researchers that take place at one institution and are simulcast to partner centers and the public worldwide, reaching thousands of viewers.
Ian Pavelich (Dunham Group) has been awarded an Advancing Science in America or ARCS Fellowship. The ARCS Foundation advances science and technology in the United States by providing financial awards to academically outstanding U.S. citizens studying to complete degrees in science, engineering and medical research. The awards are focused on helping researchers at the startup or “seed stage” of their work and discovery.
Ian’s project is titled “Molecular mechanisms of antibiotic tolerance.” “The project focuses on identifying the molecular mechanism for how pathogenic bacteria confer an antibiotic tolerance phenotype or behavior without the requirement for genetic mutations,” says Ian. “Currently, we’re attempting to identify how different stresses, like classes of antibiotics, activate different enzymes that trigger antibiotic tolerance.” The research has potential implications for the future of public health: “As modern medicine would be impossible without the use of antibiotics, further investigating these novel systems as potential new antimicrobial strategies is incredibly important.”
The ARCS Award is an unrestricted $7,500 award given directly to the scientist and may be renewed for up to three years. When asked how the ARCS Award will affect his work, Ian says: “I think that ARCS will provide a layer of flexibility in how we choose to answer the questions targeted by my research. I am extremely grateful that the ARCS committee granted me these funds, and with them I aim to expand the scope of my studies using more interdisciplinary approaches. I also plan to use funds to attend a range of diverse conferences.”
Outside the lab, Ian has been involved in outreach at Emory, working on a chemistry event during the annual Science Olympiad for area high school students that focused on fundamental gas laws and their quantitative uses. Ian’s ties to Emory go beyond chemistry, too. This month, his partner will be joining the Political Science Department graduate program at Emory: “we’ll be doing our PhDs side by side!”
The Egap Group, led by Eilaf Egap, is an interdisciplinary research team interested in developing novel and well–defined macromolecular structures, elucidating structure-property relationships, and engineering new and creative technologies that address societal challenges in human health and alternative energy.